News NEURONES

Stocks

NRO

FR0004050250

IT Services & Consulting

Real-time Euronext Paris 02:54:30 31/10/26 am AEDT			5-day change	1st Jan Change
38.20 ^EUR	+0.53%		+4.66%	-11.27%

21/09	Neurones S.A.(ENXTPA:NRO) added to S&P Global BMI Index	CI
10/09	NEURONES Reaffirms Earnings Guidance for the Full Year of 2026	CI

All News

Mentions Relevance

21/09	Neurones S.A.(ENXTPA:NRO) added to S&P Global BMI Index	CI
10/09	NEURONES Reaffirms Earnings Guidance for the Full Year of 2026	CI
10/09	Neurones S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
10/09	Neurones posts higher first-half results
10/09	NEURONES: 6.9% net profit in 1st half 2026	GL
06/08	Neurones posts strong growth
06/08	NEURONES: Organic growth up 8% in 2nd quarter 2026	GL
06/08	NEURONES Raises Earnings Guidance for the Full Year 2026	CI
06/08	Neurones S.A. Reports Revenue Results for the Second Quarter and First Half of 2026	CI
30/06	NEURONES: Declaration of transactions on treasury shares (June 22 to 26, 2026)	GL
23/06	NEURONES: Declaration of transactions on treasury shares (June 15 to 19, 2026)	GL
15/06	NEURONES: Declaration of transactions on treasury shares (June 8 to 12, 2026)	GL
08/06	NEURONES: Declaration of transactions on treasury shares (June 1 to 5, 2026	GL
05/06	NEURONES: Description of the share buyback program	GL
04/06	Neurones S.A.'s Equity Buyback announced on October 21, 2025, has expired.	CI
01/06	NEURONES: Declaration of transactions on treasury shares (May 25 to 29, 2026)	GL
26/05	NEURONES: Declaration of transactions on treasury shares (May 18 to 22, 2026)	GL
18/05	NEURONES: Declaration of transactions on treasury shares (May 11 to 15, 2026)	GL
12/05	NEURONES: Declaration of transactions on treasury shares (May 4 to 8, 2026)	GL
07/05	Neurones reports solid organic growth in Q1
07/05	Neurones sees 2026 revenues around EUR 900 million	RE
07/05	NEURONES : 5.6 % increase in organic growth in the first quarter of 2026	PU
07/05	NEURONES: + 5.6% organic growth in Q1 2026	GL
07/05	Neurones S.A. Provides Earnings Guidance for the Full Financial Year 2026	CI
07/05	Neurones S.A. Announces Revenue Results for the First Quarter of 2026	CI